Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD35 antibody (FITC)

This anti-CD35 antibody is a Mouse Monoclonal antibody detecting CD35 in FACS, WB, IHC (p), IHC (f), IP and ICC. Suitable for Human.
Catalog No. ABIN2144577

Quick Overview for CD35 antibody (FITC) (ABIN2144577)

Target

See all CD35 (CR1) Antibodies
CD35 (CR1) (Complement Component Receptor 1 (CD35) (CR1))

Reactivity

  • 120
  • 27
  • 25
  • 17
  • 16
  • 16
  • 16
  • 4
  • 3
Human

Host

  • 76
  • 48
  • 3
Mouse

Clonality

  • 89
  • 35
  • 3
Monoclonal

Conjugate

  • 54
  • 11
  • 10
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD35 antibody is conjugated to FITC

Application

  • 69
  • 39
  • 38
  • 32
  • 20
  • 20
  • 19
  • 18
  • 18
  • 14
  • 13
  • 13
  • 11
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Clone

4AE11
  • Characteristics

    4AE11 reacts with CR1 , the receptor for the complement component C3b /C4, composed of four different allotypes (160, 190, 220 and 150 kDa). CD35 antigen is expressed on erythrocytes, neutrophils, monocytes, B -lymphocytes and 10-15 % of T -lymphocytes. CD35 is catagorized as a regulator of complement avtivation. It binds complement components C3b and C4b, mediating phagocytosis by granulocytes and monocytes . Application: Removal and reduction of excessive amounts of complement fixing immune complexes in SLE and other auto-immune disorder.This clone is cross reactive with non-human primate.

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Assay Procedure

    • Take 100 μL peripheral blood anticoagulated by EDTA and add to the bottom of 5 mLtube,
    • Add 10 μL labeled antibody to the bottom of flow tube mixing with the whole blood, incubate for 20 minutes at room temperature away from light,
    • Add 2 ml1×RBC lysis buffer, incubate for 10 minutes away from light after mixing, dissolve red blood cells (recommended: RBC lysing Solution 10×,Cat.: FXP001),
    • Sample tube is set to 1000 rpm centrifugation for 5 minutes, discard the supernatant,
    • Add 2 mLPBS wash buffer to resuspend the cells, then1000 rpm centrifugation for 5 minutes, discard the supernatant,
    • Add 0.5 mLPBS wash buffer to resuspend the cells and detect by flow cytometry (sample should be determined on the day on the machine and can also be added fixation overnight at 4 °C then measured).
    • [PBS wash buffer: PBS +1 % FBS +0.1 % NaN3, Cat.: FXP005]
    • [Cell fixation: 2 % formaldehyde solution]

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Phosphate-buffered solution, pH 7.4, containing and 0.2 % (w/v) BSA

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C
  • Target

    CD35 (CR1) (Complement Component Receptor 1 (CD35) (CR1))

    Alternative Name

    CD35

    Pathways

    Complement System, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Endopeptidase Activity
You are here:
Chat with us!